Berlin - Klaus Wowereit, who as Governing Mayor of Berlin serves as both mayor of the city and governor of the state, today visited MagForce Nanotechnologies AG along with representatives of the press corps. Following a company presentation and a guided tour through MagForce’s new office and laboratory facility, the mayor met with Dr. Uwe Maschek, CEO of MagForce Nanotechnologies, and Dr. Andreas Jordan, founder and Chief Scientific Officer, who presented and explained the current status and next steps for obtaining regulatory approval as well as the commercialization phase to follow. Mayor Wowereit also expressed interest in the company’s plans for further research and for the expected business development associated with these.

"We are extremely pleased about the visit of Klaus Wowereit and his acknowledgement of our many years of commitment to Berlin as a world business center. From the initial idea, through the many years of basic research followed by many more years of patient treatment within the context of clinical studies, the entire development of our new Nano-Cancer® therapy has taken place in Berlin. Following European regulatory approval of our therapy, which we anticipate for the coming year, we would like to further expand sales and marketing activities as well as nanoparticle production at our new corporate headquarters in the Charlottenburg district of Berlin, thus underscoring our commitment to this world-class city," explained Dr. Andreas Jordan, founder and CSO of MagForce Nanotechnologies.

According to Mayor Wowereit, "MagForce Nanotechnologies AG as a company stands for the innovative power of Berlin as a world business center. It demonstrates how scientific expertise is turned here into business value. Particularly in times of economic crisis, examples like these strengthen the future of this city.

About MagForce Nanotechnologies:

MagForce Nanotechnologies AG is the world’s leading company in the area of nanotechnology-based cancer treatment. Its patented Nano-Cancer® therapy allows the targeted destruction of tumors using superparamagnetic nanoparticles to generate heat. The nanotechnology from MagForce represents a revolutionary approach to the future successful treatment of solid tumors.

Disclaimer:

This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects," "aims," "anticipates," "intends," "plans," "believes," "seeks," "estimates" or "will." Such forward-looking statements are based on our current expectations and certain assumptions which may be subject to variety of risks and uncertainties. The results actually achieved by MagForce Nanotechnologies AG may substantially differ from these forward-looking statements. MagForce Nanotechnologies AG assumes no obligation to update these forward-looking statements or to correct them in case of  developments which differ from those anticipated.